Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| SCORE |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to compare efficacy of quetiapine fumarate combined with Cognitive Remediation Therapy (CRT) to conventional treatment by evaluating change in social outcome in patients with schizophrenia.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| 1 | Experimental | quetiapine fumarate |
|
| 2 | Active Comparator | Conventional treatment for schizophrenia |
|
| 3 | Experimental | quetiapine fumarate + Cognitive Remediation Therapy |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Quetiapine fumarate | Drug | oral |
|
|
| Measure | Description | Time Frame |
|---|---|---|
| Social outcome measured by Strauss-Carpenter scale | change from baseline to last visit and end of CRT |
| Measure | Description | Time Frame |
|---|---|---|
| Change in PANSS total score | change from baseline to visit 2, from baseline to end of CRT and from baseline to last visit | |
| Change in PANSS positive, negative and general psychopathology symptom subscales | change from baseline to visit 2, from baseline to end of CRT and from baseline to last visit |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Leif Lindström, | Västerås | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Research Site | Eskilstuna | Sweden | ||||
| Research Site |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| conventional treatment for schizophrenia | Drug | various standard therapies |
|
| Change in cognition as measured by a Cognitive Battery of Tests | change from baseline to end of CRT and from baseline to last visit |
| Gothenburg |
| Sweden |
| Research Site | Hisingsbacka | Sweden |
| Research Site | Huddinge | Sweden |
| Research Site | Jönköping | Sweden |
| Research Site | Lidingö | Sweden |
| Research Site | Limhamn | Sweden |
| Research Site | Lund | Sweden |
| Research Site | Malmö | Sweden |
| Research Site | Norsborg | Sweden |
| Research Site | Nyköping | Sweden |
| Research Site | Stockholm | Sweden |
| Research Site | Trollhättan | Sweden |
| Research Site | Umeå | Sweden |
| Research Site | Västerås | Sweden |
| ID | Term |
|---|---|
| D012559 | Schizophrenia |
| ID | Term |
|---|---|
| D019967 | Schizophrenia Spectrum and Other Psychotic Disorders |
| D001523 | Mental Disorders |
Not provided
Not provided
| ID | Term |
|---|---|
| D000069348 | Quetiapine Fumarate |
| ID | Term |
|---|---|
| D003987 | Dibenzothiazepines |
| D013841 | Thiazepines |
| D013846 | Thiepins |
| D013457 | Sulfur Compounds |
| D009930 | Organic Chemicals |
| D006575 | Heterocyclic Compounds, 3-Ring |
| D000072471 | Heterocyclic Compounds, Fused-Ring |
| D006571 | Heterocyclic Compounds |
Not provided
Not provided